In particular, sub-samples characterized by more aggressive tumors, such as the high tumor grade and triple negative one, or for menopausal age one, the addition of the prognostic factors, Her2 and Ki67, respectively, can help in increasing sensitivity, even though for sparsely populated sub-samples. This evidence concerns the gene ERBB2 and neoplasm.